We analyzed RNA-seq data consisting of 8 benign breast lesions, 8 ER-positive (ER+), 8 HER2-positive (HER2+), and 8 triple negative (TN) primary breast tumors (SRP019936). This evidence concerns the gene ERBB2 and breast neoplasm.